subscribe
 

"Unknown" neurological disorder behind Alzheimer´s diagnose

The very serious hereditary disease HDLS was discovered in 1984. Many HDLS patients are still incorrectly diagnosed with Alzheimer’s disease, MS or Parkinson’s disease.



Extension of Alzheimer's disease vaccine development collaboration

AFFiRiS announced completion of preclinical work packages and related payments of from GSK to AFFiRi



Healthy diet could combat Alzheimer's

Patients in the early to moderate stages of Alzheimer's Disease could have their cognitive impairment slowed or even reversed by switching to a healthier diet, according to researchers.



Alzheimer's memory problems originate with protein clumps

Using a new mouse model of Alzheimer's disease, researchers have found that Alzheimer's pathology originates in Amyloid-Beta oligomers in the brain, rather amyloid plaques.



Early diagnostic biomarker for Alzheimer's

Researchers have found that elevated cerebrospinal fluid levels of phosphorylated tau231 may be an early diagnostic biomarker for Alzheimer's disease in healthy adults.



Early detection of Alzheimer's disease

Researchers have discovered that two drugs, the benzimidazole derivatives lanzoprazole and astemizole, may be suitable for use as PET radiotracers.



Impact of Alzheimer's disease gene in healthy brains

A study demonstrated that genetic risk is expressed in the brains of even those who are healthy, but carry some risk for Alzheimer's Disease.



Alzheimer's disease and chronic heart failure

Researchers report evidence from studies in animals and humans supporting a link between Alzheimer's disease and chronic heart failure.



Women at risk from Alzheimer's

Middle-aged women with high levels of a specific amino acid in their blood are twice as likely to suffer from Alzheimer's many years later, reveals a thesis.



Alzheimer's lesions found in the retina

The eyes may be the windows to the soul, but new research indicates they also may mirror a brain ravaged by Alzheimer's disease.



Oleocanthal may help prevent, treat Alzheimer's

Oleocanthal, a naturally-occurring compound found in extra-virgin olive oil, alters the structure of neurotoxic proteins believed to contribute to the debilitating effects of Alzheimer's disease.



Rethinking Alzheimer's disease

The standard explanation for what causes Alzheimer's is known as the amyloid hypothesis, which posits that the disease results from of an accumulation of the peptide amyloid beta.



Genetics: Risk factors for Alzheimer's disease

An international team of scientists has identified two more genetic risk factors for Alzheimer's disease.



Biotechnology: Possible target for Alzheimer's treatment

Researchers have identified a novel receptor in the brain that is extremely sensitive to beta-amyloid peptide and may play a key role in early stages of Alzheimer's disease.



Vitamin D, curcumin may fight Alzheimer's

A form of vitamin D, together with a chemical found in turmeric spice called curcumin, may help stimulate the immune system to clear the brain of amyloid beta.



Possible environmental causes for Alzheimer's, diabetes

Researchers have found a substantial link between increased levels of nitrates in our environment and food with increased deaths from diseases, including Alzheimer's, diabetes mellitus and Parkinson's.



Potential Alzheimer's drug target, pharmacology study

A team of researchers have found laboratory evidence that a cluster of peptides may be the toxic agent in Alzheimer's disease.



Alzheimer's theory may be false trail

The idea that anti-inflammatory drugs might protect people struggling with dementia from Alzheimer's disease has received a blow with the online release of a study of human brain tissue.



New evidence ties gene to Alzheimer's

Of dozens of candidates potentially involved in increasing a person's risk for the most common type of Alzheimer's disease one gene that keeps grabbing researchers' attention makes a protein called neuroglobin.



Destruction of proteins linked to Alzheimer's

Investigators have shown that druglike compounds can speed up destruction of the amyloid beta proteins that form plaque in the brains of patients with the disorder.



Pages

Subscribe

Subscribe



Newsbrief

FREE NEWSBRIEF SUBSCRIPTION

To receive the Scientist Live weekly email NewsBrief please enter your details below

Twitter Icon © Setform Limited
subscribe